Bacterial keratitis is a serious and potentially sight-threatening infection of the cornea, the transparent front part of the eye. It is caused by the invasion of bacteria into the corneal tissue, often resulting from corneal trauma, contact lens use, or compromised ocular surfaces. Common bacterial culprits include Staphylococcus aureus, Streptococcus pneumoniae, and Pseudomonas aeruginosa. Symptoms of bacterial keratitis include eye pain, redness, blurred vision, sensitivity to light, and the sensation of a foreign body in the eye. Timely diagnosis is essential, typically involving a thorough eye examination and corneal cultures. Treatment for bacterial keratitis involves the prompt administration of topical antibiotics specific to the identified bacteria. Severe cases may require additional interventions such as corneal debridement or surgery. Preventive measures include proper contact lens hygiene, avoiding eye trauma, and seeking prompt medical attention for any eye injuries. Prompt and appropriate management is crucial in preventing complications and preserving visual function in cases of bacterial keratitis.
Submit your abstract Today
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan